Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA Approves Firvanq for C.diff-associated Diarrhea

CutisPharma news release; 2018 Jan 29

The FDA has approved Firvanq (vancomycin hydrochloride) oral liquid therapy to treat Clostridium difficile-associated diarrhea and enterocolitis resulting from Staphylococcus aureus.

Indications: Firvanq (vancomycin hydrochloride) for oral solution, is approved for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.

Dosage/administration: Firvanq will be available in 25 mg/mL and 50 mg/mL strengths in convenient 150 mL and 300 mL sizes. It is designed to be easy to use and has the potential to be a cost-effective alternative to existing vancomycin therapies.

Citation:

CutisPharma announces FDA approval of FIRVANQ. [news release]. Wilmington, MA: CutisPharma; January 29, 2018. http://cutispharma.com/cutispharma-announces-fda-approval-firvanq/. Accessed January 30, 2018.

This Week's Must Reads

Long-Acting Opioid Use & Risk of Infections, Clin Infect Dis; ePub 2018 Sep 15; Wiese, et al

Parenting Desires in Men & Women Living with HIV, Open Forum Infect Dis; ePub 2018 Sep 15; Cohn, et al

Increased 30-Day Mortality with CRE in Children, Open Forum Infect Dis; ePub 2018 Sep 10; Chiotos, et al

Mobile Health Intervention for PrEP in Young MSM, Clin Infect Dis; ePub 2018 Sep 15; Liu, et al

ED Visits for ADEs From Antibiotics in Children, J Pediatric Infect Dis Soc; ePub 2018 Aug 23; Lovegrove, et al

Must Reads in Antimicrobial-resistant infections

Increased 30-Day Mortality with CRE in Children, Open Forum Infect Dis; ePub 2018 Sep 10; Chiotos, et al

ED Visits for ADEs From Antibiotics in Children, J Pediatric Infect Dis Soc; ePub 2018 Aug 23; Lovegrove, et al

MRSA Infections After Hospital Discharge, Clin Infect Dis; ePub 2018 Aug 11; Nelson, et al

Inappropriate Antibiotic Use in Uncomplicated UTIs, Open Forum Infect Dis; ePub 2018 Aug 10; Durkin, et al

A Phased Approach to Implementing AMP, Am J Infect Control; ePub 2018 Aug 3; Burgess, et al